These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26450638)

  • 61. Treatment strategies in mantle cell lymphoma.
    Maddocks K; Blum KA
    Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mantle cell lymphoma.
    Densmore JJ; Williams ME
    Curr Treat Options Oncol; 2000 Aug; 1(3):281-5. PubMed ID: 12057172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
    Dreyling M; Aurer I; Cortelazzo S; Hermine O; Hess G; Jerkeman M; Le Gouill S; Ribrag V; Trněný M; Visco C; Walewski J; Zaja F; Zinzani PL
    Leuk Lymphoma; 2018 Aug; 59(8):1814-1828. PubMed ID: 29172868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.
    O'Connor OA; Wright J; Moskowitz C; Muzzy J; MacGregor-Cortelli B; Stubblefield M; Straus D; Portlock C; Hamlin P; Choi E; Dumetrescu O; Esseltine D; Trehu E; Adams J; Schenkein D; Zelenetz AD
    J Clin Oncol; 2005 Feb; 23(4):676-84. PubMed ID: 15613699
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does maintenance therapy have a role in mantle cell lymphoma treatment?
    Parrott M; Rule S
    Expert Rev Hematol; 2018 Apr; 11(4):285-292. PubMed ID: 29521148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
    Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
    Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current and emerging treatment options for mantle cell lymphoma.
    Fakhri B; Kahl B
    Ther Adv Hematol; 2017 Aug; 8(8):223-234. PubMed ID: 28811872
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Prichard M; Harris T; Williams ME; Densmore JJ
    Expert Opin Pharmacother; 2009 Apr; 10(6):983-95. PubMed ID: 19364248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
    Fayad L; Thomas D; Romaguera J
    Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
    Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
    J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor.
    Aydin R; Tezel TH
    J Glaucoma; 2018 Jun; 27(6):e113-e116. PubMed ID: 29613980
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting Wnt pathway in mantle cell lymphoma-initiating cells.
    Mathur R; Sehgal L; Braun FK; Berkova Z; Romaguerra J; Wang M; Rodriguez MA; Fayad L; Neelapu SS; Samaniego F
    J Hematol Oncol; 2015 Jun; 8():63. PubMed ID: 26048374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Smoldering mantle cell lymphoma.
    Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
    J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary ocular adnexal mantle cell lymphoma with distant spread and involvement of the contralateral eye one year later; a case report and literature review.
    Amir A; Amir B; Sheikh S
    J Surg Case Rep; 2024 Jun; 2024(6):rjae414. PubMed ID: 38863960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
    Condoluci A; Rossi D; Zucca E; Cavalli F
    Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.
    Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Belayachi L; Bento L; García-Recio M; Sánchez JM; Villalonga P; Gutiérrez A; Fernández de Mattos S
    Br J Haematol; 2016 Sep; 174(6):899-910. PubMed ID: 27220900
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unusual Presentation of Leukemic-Phase Mantle Cell Lymphoma: A Case Report.
    Alsaati AM; Alasiri MM; Alansari BA; Mulla WY; Al-Marzouki AF; Daous YM; Radhwi O
    Cureus; 2023 Jan; 15(1):e33239. PubMed ID: 36601362
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
    Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
    Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ocular Metastasis as First Presentation of Large-Cell Neuroendocrine Carcinoma.
    Chong YJ; Azzopardi M; Ng B; Salvi SM; Sreekantam S
    Case Rep Ophthalmol; 2023; 14(1):684-691. PubMed ID: 38090108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bilateral auricular nodules: A peculiar presentation of systemic mantle cell lymphoma.
    Fritz M; Dittmer M; Tinker D; Smith K; Robbins K; Goldenberg L; Fesler M; Hurley MY
    JAAD Case Rep; 2021 Jul; 13():152-155. PubMed ID: 34195328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.